Digirad Corporation (NASDAQ:DRAD), a leading provider of
cardiovascular imaging services and solid-state nuclear medicine
imaging products to physician offices, hospitals and imaging
centers, today announced financial results for the first quarter of
2006 that exceeded previous expectations, and reaffirmed guidance
for 2006. "In the first quarter of 2006 we met or exceeded our
goals for virtually every financial and operational category in
both our product business and DIS mobile imaging services," said
CEO Mark Casner. "We are encouraged by this performance, which
reflected the improving productivity of our expanded and refocused
sales organization and the impact of our targeted and data-driven
marketing initiatives. We anticipate further progress as we
continue implementing our strategy to achieve sustainable revenue
and profit growth." Casner continued, "We are meeting internal
milestones we have set for our software and technical development
programs to enhance the image quality and reliability of our
advanced Cardius(R)-3 imaging system for nuclear cardiology, and
are on plan to begin releasing these enhancements to our customers
in mid-2006. We already have rolled out a limited number of mobile
Cardius-3M systems in our DIS fleet, and the initial customer
response is positive. In addition to improving customer service, we
expect this upgrade to help reduce employee turnover and improve
resource utilization in DIS." First Quarter Results For the three
months ended March 31, 2006, consolidated revenues increased 5.5%
to $19.0 million. This compares to consolidated revenues of $18.0
million for the first quarter of 2005 and $17.4 million for the
fourth quarter of 2005. DIS revenue increased 7.3% to $13.2 million
for this year's first quarter from $12.3 million for the first
quarter of 2005, and increased sequentially compared to $12.0
million for the fourth quarter of 2005. DIS service days for the
first quarter of 2006 were 3,461 compared to 3,381 for the same
period last year, reflecting acceleration in the pace of entering
into new service contracts compared to recent quarters. Product
segment revenue, which includes sales of gamma cameras, upgrades,
accessories and maintenance revenue, increased slightly to $5.7
million for the first quarter of 2006 versus $5.6 million for the
first quarter of 2005, and increased sequentially compared to $5.4
million for the fourth quarter of 2005. Consolidated gross margin
for the three months ended March 31, 2006, declined to 23.2% from
28.7% for the first quarter of 2005, but increased sequentially
compared to 18.8% for the fourth quarter of 2005. DIS gross margin
was 21.1% for this year's first quarter compared to 29.7% for the
first quarter of 2005 and 14.7% for the fourth quarter of 2005. The
sequential increase in DIS gross margin reflected improved staff
efficiency and system utilization as well as lower depreciation
expense versus the immediately preceding quarter. Product segment
gross margin improved to 28.0% for the first quarter of 2006 versus
26.5% for the first quarter of 2005 and 27.9% for the fourth
quarter of 2005, reflecting operational efficiencies and lower
maintenance costs stemming from improved product reliability. The
net loss for the first quarter of 2006 was $2.8 million, or $0.15
per share, including share-based compensation expense of $471,000.
This compares to a net loss for the first quarter of 2005 of
$981,000, or $0.05 per share, which included share-based
compensation expense of $178,000. Before share-based compensation
expense, the net loss for the first quarter of 2006 was $2.3
million, or $0.12 per share, and the net loss for the first quarter
of 2005 was $803,000, or $0.04 per share. Cash and equivalents and
securities available for sale at March 31, 2006, were $46.8 million
compared to $49.5 million at December 31, 2005. Net inventories
declined to $4.1 million at March 31, 2006, from $5.1 million at
December 31, 2005, and $7.0 million at December 31, 2004. Second
Quarter and 2006 Guidance Casner said that effective on June 1,
2006, DIS plans no longer to provide certain stress agents used in
a portion of imaging procedures. Instead, DIS' physician customers
will provide these agents. "While we expect this change to reduce
DIS revenue by approximately $400,000 in the second quarter and
about $2.6 million for 2006 compared to what it otherwise would
have been under our original delivery model, we expect DIS gross
margin to increase by 50 to 100 basis points and little to no
impact on DIS net earnings. We will continue to seek ways to make
all of our DIS operations more efficient and profitable," he said.
Digirad management currently expects DIS revenue for the second
quarter of 2006 in the range of $12.7 million to $13.0 million,
including the impact of the change in the delivery of stress
agents. Product revenue is expected to be between $5.1 million and
$5.3 million, and consolidated revenues between $17.8 million and
$18.3 million. The consolidated loss for the second quarter
currently is expected to be between $2.8 million and $3.1 million,
including the estimated share-based compensation expense of
$400,000, or between $2.4 million and $2.7 million, before the
anticipated share-based compensation expense. For the year as a
whole, management reaffirmed its previous guidance for consolidated
revenues to be between $70.0 million and $74.0 million, consisting
of DIS revenue between $49.0 million and $51.0 million (including
the impact of the stress agent delivery change) and product revenue
between $21.0 million and $23.0 million. Management continues to
expect the consolidated loss for 2006 to be between $10.6 million
and $12.6 million, including the estimated share-based compensation
expense of $2.6 million, or between $8.0 million and $10.0 million,
before the anticipated share-based compensation expense. Note
Regarding Non-GAAP Financial Measures Because share-based
compensation expense is a non-cash accounting charge that the
company was not required to record in past periods, management
believes that its exclusion from net income (loss) provides useful
supplemental information regarding the Company's performance and
facilitates comparisons to historical operating results. Management
also uses this information for forecasting and budgeting, as it
believes that the measure is indicative of Digirad's core operating
results. Note, however, that non-GAAP net income (loss) is a
performance measure only, and does not provide any measure of the
company's cash flow or liquidity. Non-GAAP financial measures
should not be considered as a substitute for measures of financial
performance in accordance with GAAP. Conference Call Digirad has
scheduled a conference call at 11:00 a.m. ET today. A simultaneous
webcast of the call may be accessed at the Investor Relations page
of www.digirad.com. A replay will be available for one year at this
same Internet address. A telephone replay will be available for 48
hours after the call by dialing 800-642-1687, reservation #2037699.
About Digirad Digirad Corporation develops, manufactures and
markets solid-state, digital gamma cameras to hospitals, imaging
centers and physician offices. Digirad offers a comprehensive line
of solid-state nuclear gamma cameras that produce a high quality
image for use in the detection of many medical conditions,
including cardiovascular disease. Digirad's cameras are unique as
their lightweight and compact design allows them to fit easily into
small office spaces. Digirad's wholly owned subsidiaries, Digirad
Imaging Solutions and Digirad Imaging Systems, offer a
comprehensive and mobile imaging leasing and services program for
physicians who wish to perform in-office nuclear cardiology
procedures but do not have the patient volume, capital or resources
to justify purchasing a gamma camera. For more information, please
visit www.digirad.com. Digirad(R), Digirad Imaging Solutions(R) and
Cardius(R) are registered trademarks of Digirad Corporation.
Forward-Looking Statements Digirad cautions that statements
included in this press release that are not a description of
historical facts are forward-looking statements. You can identify
these statements by the fact that they do not relate strictly to
historical or current facts and use words such as "anticipate,"
"estimate," "expect," "project," "intend," "plan," "believe" and
other words and terms of similar meaning in connection with a
discussion of future operating or financial performance or events.
Examples of such statements include the statements regarding
Digirad's expected revenues and losses for the second quarter and
full year of 2006, the expectation for progress in achieving its
strategy for growth, its expectations regarding reductions in
turnover and resource utilization, and its expectations regarding
the effects of its decision to discontinue the delivery of stress
agents. The inclusion of these and other forward-looking statements
should not be regarded as a representation by Digirad that any of
its plans will be achieved. Actual results may differ materially
from those set forth in this press release due to the risks and
uncertainties inherent in Digirad's business, including, without
limitation: the degree to which personnel changes and related
disruptions in our business activities may affect Digirad's
products, customers, work force, suppliers, and our overall
business prospects and operations; the degree to which Digirad's
camera systems and related services and improvements to its camera
systems or new service offerings will be accepted by physicians and
hospitals, some of whom may experience reliability issues or
technical problems; the ability of Digirad to effectively market,
sell and distribute its medical devices, and related services given
its limited capabilities in these areas; Digirad's ability to
manage risks relating to product liability, warranty claims,
recalls, property damage and personal injury with respect to its
imaging systems; and other risks detailed in Digirad's Securities
and Exchange Commission filings, including its Annual Report on
Form 10-K and other reports filed with the Securities and Exchange
Commission. Given these uncertainties, readers are cautioned not to
place undue reliance on these forward-looking statements, which
speak only as of the date hereof. All forward-looking statements
are qualified in their entirety by this cautionary statement and
Digirad undertakes no obligation to revise or update this press
release, including the forward-looking statements contained herein
to reflect events or circumstances after the date hereof or to
update the reasons actual results could differ materially from
those anticipated in these forward-looking statements, even if new
information becomes available in the future. -0- *T Digirad
Corporation Condensed Consolidated Statements of Operations (in
thousands, except per share amounts) (Unaudited) Three Months Ended
March 31, -------------------------------- 2006 2005
-------------------------------- Revenue: DIS $ 13,217 $ 12,322
Product 5,738 5,648 ---------------- --------------- Total revenue
18,955 17,970 Cost of revenue: DIS 10,432 8,659 Product 4,130 4,154
---------------- --------------- Total cost of revenue 14,562
12,813 ---------------- --------------- Gross profit 4,393 5,157
Operating expenses: Research and development 1,096 922 Sales and
marketing 2,459 2,039 General and administrative 4,129 3,405
Amortization and impairment of intangible assets 9 16
---------------- --------------- Total operating expenses 7,693
6,382 ---------------- --------------- Loss from operations (3,300)
(1,225) Interest and other, net 496 244 ----------------
--------------- Net loss $ (2,804) $ (981) ================
=============== Net loss per share -- basic and diluted $ (0.15) $
(0.05) ================ =============== Weighted average shares
outstanding: Basic and diluted 18,710 18,105 ================
=============== The composition of stock-based compensation is as
follows: Cost of DIS Revenue $ 20 $ 34 Cost of Product revenue 18
25 Research and development 42 22 Sales and marketing 75 21 General
and administrative 316 76 ---------------- --------------- $ 471 $
178 ================ =============== Digirad Corporation Condensed
Consolidated Balance Sheets (in thousands) Assets March 31,
December 31, 2006 2005(1) (Unaudited)
------------------------------- Cash and cash equivalents $ 17,127
$ 16,303 Securities available-for-sale 29,651 33,202 Accounts
receivable, net 9,026 8,132 Inventories, net 4,137 5,136 Other
current assets 1,557 1,687 ---------------- --------------- Total
current assets 61,498 64,460 Property and equipment, net 9,600
9,582 Intangibles, net 454 402 Restricted cash 60 60
---------------- --------------- Total assets $ 71,612 $ 74,504
================ =============== Liabilities and stockholder's
equity Accounts payable $ 2,565 $ 2,152 Accrued compensation 2,425
2,585 Accrued warranty 779 825 Other accrued liabilities 4,112
4,614 Deferred revenue 2,869 2,858 Current portion of long-term
debt 593 766 ---------------- --------------- Total current
liabilities 13,343 13,800 Long-term debt, net of current portion
298 368 Deferred rent 336 348 Total stockholder's equity 57,635
59,988 ---------------- --------------- Total liabilities and
stockholder's equity $ 71,612 $ 74,504 ================
=============== (1) The condensed consolidated balance sheet as of
December 31, 2005, has been derived from the audited financial
statements as of that date. Digirad Corporation Reconciliation of
Non-GAAP to GAAP Results of Operations (in thousands, except per
share amounts) (Unaudited) Three Months Ended March 31, 2006 As
Non-GAAP Non- Reported Adjustments(a) GAAP Gross profit $ 4,393 $
38(b) $ 4,431 Operating expenses 7,693 (433)(b) 7,260 Loss from
operations (3,300) 471(b) (2,829) Net loss $(2,804) $ 471 $(2,333)
Loss per share, basic and diluted $ (0.15) $ (0.12) Shares used in
computing loss per share (in thousands): Basic and diluted 18,710
18,710 Three Months Ended March 31, 2005 As Non-GAAP Non-GAAP
Reported Adjustments(a) Gross profit $ 5,157 $ 59(c) $ 5,216
Operating expenses 6,382 (119)(c) 6,263 Loss from operations
(1,225) 178(c) (1,047) Net loss $ (981) $ 178 $ (803) Loss per
share, basic and diluted $ (0.05) $ (0.04) Shares used in computing
loss per share (in thousands): Basic and diluted 18,105 18,105 (a)
These adjustments reconcile the Company's GAAP results of
operations to its non-GAAP results of operations. The Company
believes that presentation of results, excluding items such as
non-cash, stock-based compensation, provides meaningful
supplemental information to both management and investors that is
indicative of the Company's core operating results and facilitates
comparison of operating results across reporting periods. The
Company uses these non-GAAP measures when evaluating its financial
results as well as for internal planning and forecasting purposes.
In addition, management's bonus compensation is based on its
performance against these non-GAAP measures. These non-GAAP
measures should not be viewed as a substitute for the Company's
GAAP results. The Company adopted the fair-value recognition
provisions of SFAS No. 123 revised (123R) to expense stock-based
compensation in its fiscal quarter ended March 31, 2006. Prior to
the adoption of SFAS No. 123R, the Company accounted for employee
stock-based compensation using the intrinsic value method
prescribed by APB No. 25 and the disclosure-only provisions of SFAS
No. 123. (b) These adjustments reflect the non-cash, stock-based
compensation expense as measured under SFAS No. 123R related to
unvested stock options. The fair-value calculated expense as
determined on the awards' grant date is recognized as the awards
vest. (c) These adjustments reflect the non-cash, stock-based
compensation expense as measured under APB No. 25 related primarily
to stock option grants awarded immediately prior to the Company's
initial public offering in June 2004. Note that neither the
Company's GAAP nor non-GAAP results of operations in fiscal year
2005 included the accounting impact had the Company chosen to apply
the fair-value recognition provisions of SFAS No. 123R. *T
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From May 2024 to Jun 2024
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Jun 2023 to Jun 2024